You are here: Industry Insights > COVID-19

News List

BambooHR Launches COVID-19 Vaccination Tracking Feature prnewswire
December 08, 2021
BambooHR?, the industry's leading cloud-hosted software provider dedicated to powering the strategic evolution of human resources, today announced a new COVID-19 tab...
Convalescent Plasma Not Recommended in COVID-19 Drugs
December 08, 2021
Convalescent plasma is not recommended for patients with nonsevere, severe, or critical COVID-19, according to a living World Health Organization guideline published online Dec. 7 in The BMJ.
Chinese mainland reports 60 locally transmitted COVID-19 cases NMPA/Xinhua
December 08, 2021
The Chinese mainland on Monday reported 60 new locally transmitted COVID-19 cases, the National Health Commission said in its daily report on Dec 6.
EMA CHMP recommends granting approval for Roche’s therapy to treat Covid-19 Pharmaceutical-Technology
December 08, 2021
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended EU marketing authorisation for Roche’s Actemra/RoActemra (tocilizumab) to treat adult Covid-19 patients.
Omicron: Parliamentary panel recommends evaluation of vaccines, more research for booster dose expresspharma
December 07, 2021
The Parliamentary Standing Committee on Health, which presented its report recently, also said that concerns with regard to the new strain developing immunoescape mechanism should be critically addressed
CHMP recommends EU approval of Actemra/RoActemra to treat patients with severe COVID-19 expresspharma
December 07, 2021
Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase-III studies. The European Commission is expected to make a final decision regarding approval in the near future.
Next virus could be more lethal than COVID-19, warns Oxford vaccine creator PharmaTimes
December 07, 2021
With the emergence of the new Omicron variant bringing into question the effectiveness of current vaccines, scientists caution that viruses will continue to evolve.
Rapid test identifies antibody effectiveness against COVID-19 variants WorldPharmaNews
December 07, 2021
Biomedical engineers at Duke University have devised a test to quickly and easily assess how well a person’s neutralizing antibodies fight infection from multiple variants of COVID-19 such as Delta and the newly discovered Omicron variant.
Merck to Supply Up to 1 Million Courses of Molnupiravir, an Oral Antiviral Medicine for the Treatment of COVID-19, to Canadian Govt AmericanPharmaceuticalReview
December 07, 2021
Merck has entered into a Supply Agreement with the Government of Canada for up to 1 million patient courses of molnupiravir, its investigational oral antiviral medicine for the treatment of COVID-19. This investigational medicine is being developed by...
Cold Chain Market 2021 2026 - Global Overview by Component, Logistics, Technology, Temperature Type, Type, Deployment Type, Application, and Region prnewswire
December 07, 2021
The "Cold Chain Market Research Report by Component, Logistics, Technology, Temperature Type, Type, Deployment Type, Application, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report...